Overview
ABBOTT LABORATORIES
Latest 10-K: FY2025, filed Feb 20, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $44.33B
- 5.7%YoYup from FY2024
- TotalRevenue
- Gross profit
- $25.01B
- 7.6%YoYup from FY2024
- GrossProfit
- Operating income
- $8.05B
- 18.0%YoYup from FY2024
- OperatingIncome
- Net income
- $6.52B
- 51.3%YoYdown from FY2024
- NetIncome
- Diluted EPS
- $3.72
- 51.3%YoYdown from FY2024
- EPSDiluted
- Diluted shares
- 1.75B
- 0.0%YoYunchanged from FY2024
- WeightedAvgSharesDiluted
At a glance
Growth
- ABBOTT LABORATORIES reported revenue of $44.33B for fiscal 2025, up 5.7% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 2 of the last 5 fiscal years.
Profitability
- Operating margin was 18.2% and net margin was 14.7%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.
Per share
- Diluted EPS was $3.72, down 51.3% from the prior year.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 30, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $44.33B5.7%up Benchmark median 6.4% | $41.95B4.6%up Benchmark median 4.5% | $40.11B8.1%down Benchmark median 4.8% | $43.65B1.3%up Benchmark median 10.3% | $43.08B24.5%up Benchmark median 13.8% | 0.7% Benchmark median 6.6% |
| Gross Profit Median of 315 / 498 | $25.01B7.6%up Benchmark median 6.8% | $23.24B5.0%up Benchmark median 5.5% | $22.13B9.7%down Benchmark median 5.2% | $24.51B0.1%down Benchmark median 8.3% | $24.54B25.2%up Benchmark median 15.7% | 0.5% Benchmark median 6.2% |
| Operating Income Median of 373 / 498 | $8.05B18.0%up Benchmark median 7.3% | $6.83B5.4%up Benchmark median 7.4% | $6.48B22.5%down Benchmark median 4.9% | $8.36B0.7%down Benchmark median 7.5% | $8.43B57.3%up Benchmark median 23.5% | -1.1% Benchmark median 7.2% |
| Net Income | $6.52B51.3%down Benchmark median 4.8% | $13.40B134.2%up Benchmark median 5.7% | $5.72B17.5%down Benchmark median 1.9% | $6.93B2.0%down Benchmark median 1.3% | $7.07B57.3%up Benchmark median 33.9% | -2.0% Benchmark median 4.1% |
| EPS (Diluted) | $3.7251.3%down Benchmark median 6.2% | $7.64134.4%up Benchmark median 7.9% | $3.2616.6%down Benchmark median 1.9% | $3.910.8%down Benchmark median 1.5% | $3.9457.6%up Benchmark median 34.8% | -1.4% Benchmark median 5.6% |
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $86.71B6.5%up Benchmark median 5.6% | $81.41B11.2%up Benchmark median 3.4% | $73.21B1.6%down Benchmark median 4.1% | $74.44B1.0%down Benchmark median 2.2% | $75.20B3.6%up Benchmark median 6.7% | 3.6% Benchmark median 4.7% |
| Total Liabilities Median of 357 / 498 | — | — | — | — | — | — Benchmark median 4.4% |
| Stockholders' Equity | $52.77B10.2%up Benchmark median 6.8% | $47.90B23.4%up Benchmark median 5.4% | $38.83B5.2%up Benchmark median 7.3% | $36.91B2.4%up Benchmark median 2.5% | $36.02B9.2%up Benchmark median 9.0% | 10.0% Benchmark median 6.1% |
| Cash & Equivalents | $8.52B11.9%up Benchmark median 5.2% | $7.62B10.4%up Benchmark median 1.9% | $6.90B30.2%down Benchmark median 6.7% | $9.88B0.8%up Benchmark median -8.6% | $9.80B43.3%up Benchmark median -2.9% | -3.4% Benchmark median 2.0% |
| Total Debt | $12.93B8.5%down Benchmark median 2.1% | $14.13B3.8%down Benchmark median 0.2% | $14.68B12.5%down Benchmark median 0.3% | $16.77B7.1%down Benchmark median 0.1% | $18.05B3.7%down Benchmark median -0.1% | -8.0% Benchmark median 4.3% |
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.57B11.8%up Benchmark median 6.3% | $8.56B17.9%up Benchmark median 4.8% | $7.26B24.2%down Benchmark median 9.9% | $9.58B9.0%down Benchmark median -0.7% | $10.53B33.3%up Benchmark median 10.7% | -2.4% Benchmark median 7.0% |
| Capital Expenditures | $2.17B1.6%down Benchmark median 5.4% | $2.21B0.2%up Benchmark median 2.8% | $2.20B23.9%up Benchmark median 11.3% | $1.78B5.7%down Benchmark median 14.0% | $1.89B13.4%down Benchmark median 8.1% | 3.6% Benchmark median 9.0% |
| Free Cash Flow Median of 378 / 498 | $7.39B16.4%up Benchmark median 7.3% | $6.35B25.5%up Benchmark median 6.1% | $5.06B35.2%down Benchmark median 8.8% | $7.80B9.8%down Benchmark median -11.3% | $8.65B51.1%up Benchmark median 10.2% | -3.8% Benchmark median 4.9% |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
3.0%
Wall Street
on net earnings
FY2024 6.8%
3.4%
Value investor
on free cash flow
FY2024 3.2%
Gap +0.4 pts: Value-investor figure 0.4 points higher
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E 33.7×Value investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Valuation · Enterprise yield
What a dollar of enterprise value earned
4.4%
Wall Street
on EBITDA
FY2024 4.3%
3.6%
Value investor
on EBIT
FY2024 3.3%
Gap −0.8 pts: Value-investor figure 0.8 points lower
How it’s calculated
Wall Street · on EBITDA
EBITDA ÷ enterprise value (1 ÷ EV/EBITDA)
ev_ebitda (ratio table)
EV/EBITDA 22.9×Value investor · on EBIT
Operating income (EBIT) ÷ enterprise value: depreciation counts as a real cost
operating income ÷ (ev_ebitda × ebitda)
Valuation · Book yield
Net assets behind a dollar of market value
24.1%
Wall Street
on book equity
FY2024 24.2%
10.6%
Value investor
on tangible book
FY2024 9.2%
Gap −13.5 pts: Value-investor figure 13.5 points lower
How it’s calculated
Wall Street · on book equity
Book value of equity ÷ market capitalisation (1 ÷ P/B)
pb_ratio (ratio table)
P/B 4.2×Value investor · on tangible book
Tangible book value (equity less goodwill and intangibles) ÷ market capitalisation
tangible_book_value_per_share ÷ (pb_ratio × book_value_per_share)
Quality · Return on capital
Profit earned on the money in the business
13.0%
Wall Street
ROE: net income ÷ equity
FY2024 30.9%
9.6%
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 11.2%
Gap −3.4 pts: Value-investor figure 3.4 points lower
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
22.0%
Wall Street
EBITDA margin
FY2024 20.7%
16.7%
Value investor
Free-cash-flow margin
FY2024 15.1%
Gap −5.3 pts: Value-investor figure 5.3 points lower
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
1.58×
Wall Street
Current ratio
FY2024 1.67×
1.18×
Value investor
Quick ratio, inventory excluded
FY2024 1.23×
Gap −0.40×: Value-investor figure 0.40 lower
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
0.75×
Wall Street
EBITDA ÷ total debt
FY2024 0.62×
0.57×
Value investor
FCF ÷ total debt
FY2024 0.45×
Gap −0.18×: Value-investor figure 0.18 lower
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Net debt/EBITDA 0.41×Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Balance sheet · Interest cover
How many times earnings pay the year's interest
19.7×
Wall Street
EBITDA ÷ interest
FY2024 15.6×
16.3×
Value investor
EBIT ÷ interest
FY2024 12.2×
Gap −3.4×: Value-investor figure 3.4 lower
How it’s calculated
Wall Street · EBITDA ÷ interest
EBITDA ÷ interest expense
ebitda_interest_coverage (ratio table)
Value investor · EBIT ÷ interest
Operating income ÷ interest expense
interest_coverage (ratio table)
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on ABT yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ABT and publish the result to your public profile.
Cite this page
Data as of Oct 30, 2026. Canonical address: https://valuein.biz/data/ABT
Valuein. (2026, October 30). ABBOTT LABORATORIES (ABT) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/ABT
@misc{valuein_abt_2026,
author = {{Valuein}},
title = {ABBOTT LABORATORIES (ABT) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/ABT}},
note = {Data as of 2026-10-30; source: SEC EDGAR filings}
}10-K filed Feb 20, 2026 · accession 0001628280-26-010185
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.